文献综述(Review)

肝门部胆管癌的外科治疗现状

Published at: 2017年第26卷第2期

晏益核 1 , 黄玉斌 1 , 蔡小勇 1
1 广西医科大学微创外科中心/第二附属医院 普通外科,广西 南宁 530007
通讯作者 益核 晏 Email: yiheyan@hotmail.com
DOI: 10.3978/j.issn.1005-6947.10.3978/j.issn.1005-6947.2017.02.019
基金:
广西医科大学青年科学基金资助项目 GXMUYSF201508

摘要

肝门部胆管癌(HC)虽然发生率低,但预后较差,而外科手术仍是目前的唯一治愈手段。经历半个多世纪的发展,HC的外科治疗获得极大进展,随之而来的争议仍然存在。笔者就HC的术前分期及治疗、手术切除范围、血管切除与重建、淋巴结清扫数目及范围、腹腔镜手术、肝移植应用等方面的现状展开论述,为HC外科治疗提供借鉴。


Current status in surgical management of hilar holangiocarcinoma

Abstract

Although the prevalence of hilar cholangiocarcinoma (HC) is relatively low, it is associated with dismal prognosis, and surgical resection remains the only curative treatment for this condition. Over more than half a century, considerable achievements have been made in surgical treatment of HC, meanwhile, the accompanied controversies still exist. The authors, in this paper, discuss the issues concerning the preoperative staging and management, and surgical resection scope, combined vascular resection with reconstruction, number and scope of lymph node dissection, laparoscopic procedure and liver transplantation for HC, so as to provide helpful guidance for surgical management of HC.


comments powered by Disqus

全文

引用

引用本文: 益核 晏, 玉斌 黄, 小勇 蔡. 肝门部胆管癌的外科治疗现状 [J]. 中国普通外科杂志, 2017, 26(2): 246-251.
Cite this article as: YAN Yihe, HUANG Yubin, CAI Xiaoyong . Current status in surgical management of hilar holangiocarcinoma [J]. Chin J Gen Surg, 2017, 26(2): 246-251.